CRISPR-Cas Systems and Genome Editing: Beginning the Era of CRISPR/Cas Therapies for Humans
Author:
Affiliation:
1. Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilov Str. 32, Moscow 119991, Russia
Abstract
Funder
Ministry of Science and Higher Education of the Russian Federation
Publisher
MDPI AG
Link
https://www.mdpi.com/1422-0067/25/10/5292/pdf
Reference47 articles.
1. Ding, W., Zhang, Y., and Shi, S. (2020). Development and Application of CRISPR/Cas in Microbial Biotechnology. Front. Bioeng. Biotechnol., 8.
2. CRISPR-Cas systems: Overview, innovations and applications in human disease research and gene therapy;Xu;Comput. Struct. Biotechnol. J.,2020
3. Pioneers of revolutionary CRISPR gene editing win chemistry Nobel;Ledford;Nature,2020
4. Vicente, M.M., Chaves-Ferreira, M., Jorge JM, P., Proenca, J.T., and Barreto, V.M. (2021). The Off-Targets of Clustered Regularly Interspaced Short Palindromic Repeats Gene Editing. Front. Cell Dev. Biol., 9.
5. CRISPRCasdb a successor of CRISPRdb containing CRISPR arrays and cas genes from complete genome sequences, and tools to download and query lists of repeats and spacers;Pourcel;Nucleic Acids Res.,2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3